Policy Briefs
An overview of the pharmaceutical market for Tenofovir-EmtricitabineEfavirenz (TEE) and Tenofovir-Lamivudine-Dolutegravir (TLD) within the South African private sector
TEE: Private-sector market overview (Aug-19 to Jul-20)
For further information on TLD(Tenofovir, Lamivudine, Dolutegravir) volumes, estimates of patient numbers and payment-methods for the private-sector (Aug-19 to Jul-20) use the above link.